• Fri news: New Novo obesity prospect linked to psychiatric side effects. Summit beats Keytruda in NSCLC. DermaSensor skin cancer detection device. Astellas digital health product. Sanofi MS data. See more on our front page

Sandoz to Commercialize Samsung Bioepis’ Biosimilar to J&J’s Stelara

cafead

Administrator
Staff member
  • cafead   Sep 12, 2023 at 11:02: AM
via Sandoz on Monday signed a development and commercialization contract with Samsung Bioepis for SB17, the latter’s biosimilar to Johnson & Johnson’s Stelara (ustekinumab).

article source
 

<